NCT06566911 Voice Analysis for Monitoring Patients With Heart Failure
| NCT ID | NCT06566911 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Noah Labs |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-01-24 |
| Primary Completion | 2024-09 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.
Eligibility Criteria
Inclusion Criteria: * Clinically diagnosed with Acutely Decompensated Heart Failure. * At least 18 years of age. Exclusion criteria: * Disabling mental diseases (e.g., Alzheimer's disease) * Clinically diagnosed chronic obstructive pulmonary disease (COPD) * Treatment in ICU or IMU * Dialysis treatment * Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.) * Neurodegenerative diseases * Pregnancy * Inability to provide consent
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.